Preeclampsia: Pathophysiology and practice considerations for the consulting nephrologist

Seminars in Nephrology

Volumn 22, Issue 1, 2002, Pages 54-64

  Isler, Christy M ^a   Martin Jr , James N ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSULTATION; CYTOKINE RELEASE; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; IMMUNE RESPONSE; IMPLANTATION; MALADJUSTMENT; MEDICAL PRACTICE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW;

CYTOKINES; FEMALE; HUMANS; ISCHEMIA; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 0036144516     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Pregnancy-related mortality in the United States, 1987- 1990
2. Eklampsie
3. Preeclampsia: What we know and what we do not know
4. Pathogenesis of preeclampsia: A comprehensive model
5. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants
6. The role of spiral arteries in the pathogenesis of preeclampsia
7. The placental bed
8. Preeclampsia: More than pregnancy-induced hypertension
9. The placenta in pregnancy hypertension
10. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype
11. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta
12. Expression of vascular endothelial growth factor in human placenta
13. VEGF mRNA levels in placentae from pregnancies complicated by preeclampsia
14. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia
15. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts
16. Beta 1 integrins in third trimester human placentae: No differential expression in pathological pregnancies
17. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes
18. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy
19. An epidemiologic study of contraception and preeclampsia
20. Barrier contraceptive methods and preeclampsia
21. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception
22. Correlation between oral sex and a low incidence of preeclampsia: A role for soluble HLA in seminal fluid?
23. Immune basis for preeclampsia evidence from oocyte recipients
24. The relationship between abortion in the first pregnancy and development of pregnancy-induced hypertension in the subsequent pregnancy
25. Influence of previous blood transfusion on incidence of preeclampsia
26. The immunologic concept of pre-eclampsia
27. Mixed wife-husband leukocyte cultures in disturbed and pathological pregnancies. Further studies
28. The feto-maternal lymphocyte interaction in preeclampsia and in uncomplicated pregnancy
29. Human leucocyte antigens and mixed lymphocyte reaction in severe preeclampsia
30. Maternal cell-mediated immunity in normal and preeclamptic pregnancy
31. Cellular immunity in preeclampsia: Alterations in T-lymphocyte subpopulations during early pregnancy
32. Anti-vascular endothelial cell antibodies in severe preeclampsia
33. Acute atherosis. A histopathological hallmark of immune aggression?
34. The familial factor in toxemia of pregnancy
35. Genetics of preeclampsia
36. Preeclampsia: Discordance among identical twins
37. Genetic control of severe preeclampsia
38. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome
39. What is the place of genetics in the pathogenesis of preeclampsia?
40. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia
41. Methylenetetrahydrofolate reductase polymorphism and preeclampsia
42. Methylenetetrahydrofolate reductase polymorphism, folate and susceptibility to preeclampsia
43. A common mutation which causes hyperhomocysteinemia is not associated with pregnancy induced hypertension
44. A molecular variant of angiotensinogen associated with preeclampsia
45. Preeclampsia and the angiotensinogen gene
46. Beyond genetic markers: Hypertension genes
47. Association of preeclampsia with common coding sequence variations in the lipoprotein lipase gene
48. Apolipoprotein E polymorphism in preeclampsia
49. Severe preeclampsia associated with co-inheritance of factor V Leiden mutation and protein S deficiency
50. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region
51. The eNOS gene: A candidate for the preeclampsia susceptibility locus?
52. Short communication: An HLA-haplotype associated with preeclampsia and intrauterine growth retardation
53. Absence of close linkage between maternal genes for susceptibility to preeclampsia/eclampsia and the HLA DRB
54. An exclusion map for preeclampsia: Assuming autosomal recessive inheritance
55. HLA-G deletion polymorphism and preeclampsia/eclampsia
56. Genetic conflicts in human pregnancy
57. Current topic: Preeclampsia and the placenta
58. Preeclampsia: An endothelial cell disorder
59. Preeclampsia related to a functioning extrauterine placenta: Report of a case and 25-year follow-up
60. Underlying disorders associated with severe early-onset preeclampsia
61. Placental bed spiral arteries in the hypertensive disorders of pregnancy
62. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies
63. Immunofluorescent study of placental bed vessels in preeclampsia of pregnancy
64. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia
65. The oxidation hypothesis of atherosclerosis
66. Lipid peroxidation in pregnancy: New perspectives on preeclampsia
67. Preeclampsia and serum antibodies to oxidized low-density lipoprotein
68. Serum antibodies to oxidised low-density lipoprotein in preeclampsia and coronary artery disease
69. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells
70. Invasive cytotrophoblast manifest evidence of oxidative stress in preeclampsia
71. The neutrophil and preeclampsia
72. Endothelin, elastase, and endothelial dysfunction in preeclampsia
73. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension
74. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood
75. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy
76. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies
77. The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients
78. Preeclampsia and antioxidant nutrients: Decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia
79. Comparative study of lactoferrin and other markers of inflammatory stress between preeclamptic and normal pregnancies
80. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: A randomized trial
81. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes
82. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia
83. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small-for-gestational-age newborns
84. Interleukin-6, turnout necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia
85. What can be learned from the expression of endothelial adhesion molecules in tissues?
86. Neutrophil-mediated vascular damage
87. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia
88. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: Does this indicate the mechanism of leucocyte activation?
89. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia
90. Increased levels of intercellular adhesion molecules and vascular cell adhesion molecules in preeclampsia
91. Longitudinal plasma ICAM-1 & IFN-α in preeclampsia
92. Increased concentrations of cytokines, interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction?
93. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells
94. The possible role of endothelial cells in hypertensive disorders during pregnancy
95. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia
96. Possible mechanism of vascular damage in preeclampsia
97. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro
98. Trophoblast deportation in preeclamptic pregnancy
99. Endothelial dysfunction in preeclampsia
100. The vascular endothelium in normal pregnancy and preeclampsia
101. Endothelial vasoactive mediators in preeclampsia
102. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation
103. Biochemical corroboration of endothelial involvement in severe preeclampsia
104. Elevated circulating thrombomodulin in severe preeclampsia
105. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies
106. Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels
107. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis
108. Pregnancy related hypertension
109. Disordered eicosanoid formation in pregnancy-induced hypertension
110. Platelet angiotensin II binding sites in normotensive and hypertensive women
111. Preeclampsia: A review of the role of prostaglandins
112. 2 synthase gene
113. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production
114. 2 synthesis in pregnancy-induced hypertension
115. The duration of hypertension in the puerperium of preeclamptic women: Relationship with renal impairment and week of delivery
116. Persistent abnormalities in plasma volume and renal hemodynamics in patients with a history of preeclampsia
117. Respiratory function in severe gestational proteinuric hypertension and the effects of rapid volume expansion and subsequent vasodilatation with verapamil
118. Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia
119. Effects of low dose dopamine therapy in the oliguric patient with preeclampsia